• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET 360 ULTRA 2MM X 4CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET 360 ULTRA 2MM X 4CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Catalog Number M0035422040
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Visual Disturbances (2140)
Event Date 09/22/2015
Event Type  Injury  
Manufacturer Narrative
This is the 2nd of 5 (coils) reports filed associated with this event.Subject devices remain implanted.
 
Event Description
The patient underwent successful stent assisted coil embolization of an aneurysm located in the anterior communicating artery.It was reported that approximately 1 month post-procedure, the patient experienced diplopia (double vision).The event was resolved without any residual effects.The patient was neurologically assessed as having post-procedure mrs of 0.According to the physician, it is possible that the diplopia be related to the stent and to the procedure; it is unknown if the diplopia was related to the implanted coils (subject devices).The patient was neurologically assessed as having a nihss of 0 and mrs of 1 at 2-month follow-up.Approximately 7-month post-procedure, the patient suffered a subdural hematoma due to fall that lasted 17 days.The subdural hematoma was resolved with residual effects.Prolonged hospitalization was required.According to the physician, the subdural hematoma was not related to the procedure, or stent; however, it was unknown if it was related to the implanted coils.The patient was neurologically assessed as having mrs of 4 at 8-month follow-up.
 
Manufacturer Narrative
Expiration date: added.Manufacturing date: added.Patient code: based on medical assessment, it was concluded that the event of subdural hematoma was not related to the coils.Therefore, previously filed patient code of hematoma is no longer applicable to this report.Outcomes attributed to ae: corrected: since hematoma is not an event associated with the coils, the previously outcome attributed of "hospitalization-initial or prolonged" is no longer applicable to this report.The device history record (dhr) review confirms that the device met all material, assembly and performance specifications.The subject device was not returned for analysis; therefore, physical as well as a functional testing could not be performed.However, neurological/intracranial sequelae (visual disturbances) is a known risk associated with endovascular procedures and noted as such in the device directions for use (dfu).Therefore, an assignable cause of anticipated procedural complication was assigned to this event.
 
Event Description
The patient underwent successful stent assisted coil embolization of an aneurysm located in the anterior communicating artery.It was reported that approximately 1 month post-procedure, the patient experienced diplopia (double vision).The event was resolved without any residual effects.The patient was neurologically assessed as having post-procedure mrs of 0.According to the physician, it is possible that the diplopia be related to the stent and to the procedure; it is unknown if the diplopia was related to the implanted coils (subject devices).The patient was neurologically assessed as having a nihss of 0 and mrs of 1 at 2-month follow-up.Approximately 7-month post-procedure, the patient suffered a subdural hematoma due to fall that lasted 17 days.The subdural hematoma was resolved with residual effects.Prolonged hospitalization was required.According to the physician, the subdural hematoma was not related to the procedure, or stent; however, it was unknown if it was related to the implanted coils.The patient was neurologically assessed as having mrs of 4 at 8-month follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET 360 ULTRA 2MM X 4CM
Type of Device
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key6845807
MDR Text Key85014223
Report Number3008881809-2017-00289
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K102672
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/16/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/06/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2018
Device Catalogue NumberM0035422040
Device Lot Number18249881
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/27/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/25/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FOUR (4) TARGET COILS (STRYKER); TWO (2) NEUROFORM ATLAS STENTS (STRYKER)
Patient Outcome(s) Hospitalization; Other;
Patient Age69 YR
-
-